Projects
This section presents pharmaceutical projects that are announced from time-to-time around the world.
Thermo Fisher Constructs New cGMP Plasmid DNA Manufacturing Facility in California
Thermo Fisherplans to construct a new manufacturing facility for the production of clinical and commercial capabilities The facility will be located in Carlsbad, California The expansion of this facility enhances the commercialisation of plasmidbased medicines and vaccines
KBI Biopharma Invests $150 Millionto Expand Commercial Manufacturing Facility in North California
KBI Biopharma, Inc, plans to open a new facility for commercial manufacturing The manufacturing site involves an investment of US$150 million The facility will be located atResearch Triangle Park RTP in North Carolina
Lonza to Open Two Additional Manufacturing Suites
Lonzaplans to open two additional manufacturing sites to expand the conjugation facility
Piramal PharmaPlans New Manufacturing Facility in Michigan
Piramal Pharma Solutions plans to expand with the addition of a new manufacturing facility located in Michigan
SeqirusConstructs World Class Vaccine Manufacturing Facility in Australia
Seqirus, a global leader in influenza prevention and influenza pandemic responseplans to construct a new nextgeneration vaccine manufacturing facility The new manufacturing facility will be located in Australia
Samsung Biologics Constructs Super Plant 4 in South Korea
Samsung Biologics plans to open the most innovative biomanufacturing facility with the addition of super plant 4 The modern super plant 4 will be located in Incheon, South Korea
Cambrex to Expand Large Scale API Manufacturing Capacity in US
Cambrex plans to invest US$50 million to expand new midscale and largescale API manufacturing capacity The site will be located in Iowa, US
Vibalogics Invests US$150million to Expand Virotherapy Facility in Boston
Vibalogics with an investment of US$ 150 million plans to enter the US region to expand Virotherapy Facility The new facility will be located in Boston
Minaris Regenerative Medicine Opens New Manufacturing Sites in Europe and Asia
Minaris Regenerative Medicine plans to invest US$645 million to open new manufacturing facilities in Asia and Europe This expansion increases the cell and gene manufacturing capabilities
Metrics Expands Manufacturing Facility in North Carolina
Metrics Contract Services Metrics plans to invest US$10 million for the expansion of a novel oral solid dosage manufacturing facility in Greenville, North Carolina
